Drug Type Small molecule drug |
Synonyms PPI-1040 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC43H72NO6P |
InChIKeySKDNPCDRIUQGAL-XTJCVSPVSA-N |
CAS Registry1436673-69-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chondrodysplasia Punctata, Rhizomelic | Preclinical | Canada | 24 Jan 2020 | |
| Chondrodysplasia Punctata, Rhizomelic | Preclinical | Canada | 24 Jan 2020 | |
| Chondrodysplasia Punctata, Rhizomelic | Preclinical | Saudi Arabia | 24 Jan 2020 |





